Ashwagandha and the contraceptive pill:
what has actually been tested and what has never been tested
There is no study at all of women taking hormonal contraceptives and ashwagandha at the same time. None showing that the pill is weakened, and none showing that it is not. What does exist are three experiments on liver enzymes, a “grade D” rating in an interaction database and an overlap nobody talks about: the liver.
The short answer:
nobody knows, and that is an answer, not an evasion
The fear has a name, and that name is St John’s wort. It really does reduce the effectiveness of hormonal contraceptives, this is documented in humans, and from there the general idea that “herbs ruin the pill” has stuck in everyone’s head. Ashwagandha is not St John’s wort.
What has been tested so far are three papers on liver enzymes, none of them in women taking the pill. Two found nothing. The third, from 2025, found something, in one type of extract out of four.
What has never been tested: a single woman. There is no pharmacokinetic study in humans measuring what happens to ethinylestradiol in the blood when you also take ashwagandha. The authors of one of the papers say so explicitly: comprehensive pharmacokinetic interaction studies with ashwagandha have not been reported.
So the honest answer is neither “yes” nor “no”. It is “it has not been measured, and the signal that exists is weak and comes from a laboratory dish”. Anyone who tells you otherwise, in either direction, is giving you an opinion.
And the thing nobody says: if there is anything to watch with this combination, it is not pregnancy. It is the liver. We get there in chapter 6.
The absence of a proven interaction is not the same as an interaction proven to be absent. The first means nobody has measured it. The second means it was measured and there was nothing. We are in the first situation here.
Where the fear comes from:
the mechanism that really does undermine the pill
The combined pill contains an oestrogen, usually ethinylestradiol, and a progestogen. Both are broken down in the liver, largely by an enzyme called CYP3A4. If something speeds that enzyme up, the hormone is cleared faster, the blood level falls, breakthrough bleeding appears and, in the worst case, ovulation.
The technical term is enzyme induction. It is the opposite of what is usually tested in the laboratory, where inhibition, meaning braking, is measured. A plant that brakes the enzyme makes the medicine stronger. A plant that speeds it up makes it weaker. The pill is not undermined by the brake, it is undermined by the accelerator. Remember this distinction, it is the key to the next chapter.
This is what a real, measured interaction looks like. In 2024, a group in Heidelberg gave St John’s wort to 11 healthy volunteers for 14 days and tracked how quickly a microdose of midazolam, the marker drug for CYP3A4, disappeared from the blood.
| Daily dose of St John’s wort | What it contains | How much faster clearance becomes |
|---|---|---|
| 300 mg | 7.48 mg hyperforin | 1.96 times |
| 900 mg | the usual therapeutic dose | 3.86 times |
| 1,800 mg | the supratherapeutic dose | 5.62 times |
| 1,800 mg plus rifampicin | two inducers at once | 17.5 times |
That is what a proven interaction means: it has people, a dose, a curve and a marker. Ashwagandha has none of the four.
What has been tested with ashwagandha:
two papers on the brake, one on the accelerator
All three are experiments on cells or on liver fractions, none of them in people. Here they are in order, with what each one measured, because the difference between them is the whole article.
| Paper | What it measured | What it found |
|---|---|---|
| Frontiers in Pharmacology, 2022 | inhibition of CYP3A4, CYP2C8 and CYP2D6, in vitro | no inhibition; the authors write that ashwagandha “appears to be safe” alongside substrates of these enzymes |
| Drug Metabolism and Disposition, 2025 | inhibition of eight isoforms, four root and leaf extracts | no reversible inhibition with any extract, IC50 above 100 µg/mL |
| Journal of Dietary Supplements, 2025 | induction of CYP3A4, CYP2B6 and CYP1A2, in primary human hepatocytes | just one extract out of four modulated the expression and activity of CYP3A4: the 70% ethanol root extract |
The first two tested the brake and found nothing. They are reassuring, but they answer a different question from the one in the title, because the pill is not undermined by braking.
The third tested the accelerator, for the first time in primary human hepatocytes rather than a cell line, which is closer to a real liver. And something did show up there: the root extract made with 70% ethanol modulated CYP3A4. Just one extract out of four. The 70% ethanol leaf extract reduced cell viability, in a dose and time dependent way, which is a separate problem and is also about the liver.
The detail that matters for anyone buying a specific product: according to the manufacturer, KSM-66 extract is made from the root only and, quote, “without using alcohol or any other chemical solvent”. In other words, it is not the extract that produced a signal in 2025. This is not an acquittal, it is a distinction. Nobody tested KSM-66 in that experiment, and what is on your label matters more than what is on someone else’s.
Nothing in this chapter is a reason to stop the pill or change anything on your own. A result in cultured cells does not translate directly into what happens in a body. It translates into a question you ask your doctor, not a decision you make alone.
What the interaction databases say:
“minor”, “possible”, grade D
If you search for “ashwagandha contraceptive” in a clinical herb and drug interaction database, you will find an entry. It exists and it is real. It just says almost the opposite of what people take from the mere fact that it exists.
Severity: minor. Likelihood: possible. Level of evidence: D. The mechanism is worded as “theoretically, ashwagandha might decrease the levels and clinical effects of CYP3A4 substrates”, and the evidence cited is “in vitro research shows that ashwagandha extract induces CYP3A4 enzymes”. In other words, exactly the 2025 paper above.
Grade D is defined in that very database: documented in animal or laboratory research, or in humans only through case reports. It is the bottom rung. A grade D entry is not a warning, it is a footnote.
The comparison that settles it: the professional fact sheet of the Office of Dietary Supplements at the US National Institutes of Health lists ashwagandha’s possible interactions with antidiabetic medicines, antihypertensives, immunosuppressants and sedatives. Contraceptives do not appear on the list at all.
Not all methods are the same:
what would change if something really did induce the enzymes
Suppose, for a minute, that ashwagandha were a proven enzyme inducer. It is not, but suppose it were. Even then the answer would not be the same for everyone, because contraceptive methods do not all pass through the liver in the same way. The guidance from the UK Faculty of Sexual and Reproductive Healthcare sets this out very clearly, and it is worth knowing whatever the plant.
Oestrogen plus progestogen, metabolised in the liver. With a proven enzyme inducer, the guidance says contraceptive effectiveness could be reduced and the method is not recommended for the duration of treatment and for 28 days after stopping it. Ashwagandha is not on that list of proven inducers.
The progestogen-only pill follows exactly the same rule: effectiveness possibly reduced with a proven inducer, not recommended while taking it and for 28 days afterwards. It is also the method with the strictest timing window, so the one where a missed hour matters most anyway.
The etonogestrel implant sits under the skin, but the hormone still reaches the circulation and still passes through the liver. The same wording in the guidance: effectiveness possibly reduced, not recommended while taking an enzyme inducer and for 28 days afterwards. The fact that it is not a pill does not take it out of the discussion.
The levonorgestrel IUD, the copper IUD and the progestogen injection: the guidance says without reservation that no effect on contraceptive effectiveness is expected and that no extra precautions are needed, even with proven enzyme inducers. If this is your method, the question in the title of this article does not concern you.
For emergency contraception, the guidance is more cautious: with an enzyme inducer, the effectiveness of the pill may be reduced and a copper IUD is recommended instead, if that is an option. Again, the rule is for proven inducers.
The real overlap:
both pass through the same organ
This is the part we did not find in any Romanian-language article on this topic, and it is the only part of the whole text worth keeping in mind.
Ashwagandha and hormonal contraceptives have something in common that has nothing to do with contraceptive effectiveness: both appear in the National Institutes of Health database on drug-induced liver injury. And both with the same pattern, cholestasis.
| Ashwagandha | Oestrogens and oral contraceptives | |
|---|---|---|
| Likelihood score | B | A |
| Published cases | 23 cases of clinically apparent liver injury | a well-known cause, for decades |
| Pattern | cholestatic or mixed, with jaundice and itching | pure intrahepatic cholestasis, with minimal inflammation |
| When it appears | usually 2 to 12 weeks after starting | usually in the first cycles, rarely after six months |
| Course | usually mild or moderate, resolves within 1 to 4 months of stopping | reversible on stopping |
Two fair clarifications, so that this does not come across as more dramatic than it is. Today’s low-dose contraceptives do not raise transaminases more often than placebo, unlike the high-dose formulations of a few decades ago. And with ashwagandha, most cases were mild and resolved on their own after stopping, although there are also cases of acute liver failure, especially in people with pre-existing cirrhosis.
What has not been studied: whether the risk adds up when you take both. Nobody has measured that, just as nobody has measured the other question. But if jaundice, itching or dark urine appear in a woman taking both the pill and ashwagandha, the question “which of the two” suddenly becomes very concrete, and it is a question for a doctor with a set of liver function tests in front of them.
text
The signs that mean stopping the supplement and seeing a doctor, whatever else you are taking: yellowing of the skin or the whites of the eyes, dark urine, pale stools, itching without a rash, nausea that does not go away, pain under the right ribs, unusual tiredness. Do not stop the pill on your own, but tell the doctor everything you are taking.
What the Romanian internet says:
three pages say nothing, one warns without a source
We read the top five results in Romanian for this question before writing a single line. It is worth saying what we found, because it explains why the answer is so hard to find.
| Source | What it says about contraception |
|---|---|
| Regina Maria | nothing. It mentions the thyroid and antihypertensives, contraception not at all |
| MedLife | nothing. It mentions antidepressants, blood sugar, blood pressure and testosterone, contraception not at all |
| Catena | nothing. It mentions benzodiazepines, anticonvulsants and barbiturates |
| natu.care | “risk of interaction” with hormonal contraception, in a list with epilepsy and anticoagulants, without saying where this comes from |
| a supplement shop | “There is no absolute contraindication between ashwagandha and hormonal contraceptives, but every context is different” |
Three serious medical pages say nothing. One warns without a source. And the most accurate sentence in the top five results is on the page of a shop that sells the product, in a text that otherwise credits the plant with “hormonal balance” and “regulating the cycle”, exactly the claims it is not allowed to make.
None of the five cites a study on enzymes. This is not bad faith. It is what happens when a popular question has no published answer: the gap is filled with whatever is to hand, and what is to hand is either silence or a copied list.
Five things people say:
and what survives a fact check
Tap each one to see what we found.
St John’s wort has a dose-response curve measured in people, with a marker drug and with figures: 1.96 times at 300 mg a day, 5.62 times at 1,800 mg. Ashwagandha has nothing of the sort. It has one result in cultured human hepatocytes, with one of the four extracts tested. Putting the two in the same sentence is like putting a speed camera and a hunch in the same sentence about speed.
St John’s wort is a plant too, and it is the reason contraception guidance has a chapter on enzyme inducers. “Natural” is not a pharmacological category. The right argument in the case of ashwagandha is not that it is a plant, but that nobody has measured the effect in humans.
Ashwagandha has no authorised health claim in the European Union. It is not a contraceptive, it does not regulate the cycle and nobody has the right to write that it does.
The actual rating, in a clinical herb and drug interaction database, is severity “minor”, likelihood “possible”, level of evidence D. Grade D is defined right there as “documented in animal or laboratory research, or in humans only through case reports”. So the entry exists, but it says exactly the opposite of what people take from it.
Breakthrough bleeding is one of the most common effects of hormonal contraceptives in the first months, whatever else you are taking. It is not proof of an interaction and not a reason to stop the pill on your own. It is a reason to call your doctor and tell them everything you take, the supplement included.
In pregnancy and breastfeeding, ashwagandha is not taken. The National Institutes of Health fact sheet says some experts discourage it in pregnancy, because some reports have suggested a potential for miscarriage. Here it is not “maybe”, it is “no”, and that holds whatever contraception you were using before.
What is in our gummies
with KSM-66 ashwagandha
Our Ashwagandha KSM-66 is a gummy. Two gummies a day means 600 mg of extract standardised to 5% withanolides.
What it is not, and this is worth saying plainly in an article on this subject: it is not a contraceptive, it does not regulate your cycle and it does not replace anything a doctor has prescribed for you.
A detail that matters for the very question in chapter 3. The manufacturer of KSM-66 extract says it is obtained from the root only and without alcohol or any other chemical solvent, which means it is precisely not the type of extract that produced a CYP3A4 signal in 2025. When you compare two boxes of ashwagandha, this is the distinction worth looking for, not the number of milligrams.
The product in this articleAshwagandha KSM-66, in gummies600 mg of extract standardised to 5% withanolides, two gummies a day. Root-only extract, no chemical solvent.View the productIf you have ended up here because you take several things at once, also read what the studies show about ashwagandha and the thyroid, where the interaction really is documented, and which supplements should not be taken together and at what time.
Frequently asked questions:
what you ask us most often
There is no study in humans showing that. The mechanism people fear, the speeding up of the CYP3A4 enzyme, was only tested in human hepatocytes in 2025, and it appeared with just one type of extract, the one made with 70% ethanol. A result in a laboratory dish is not an unwanted pregnancy. Still, tell the doctor who prescribed your pill that you are taking the supplement.
No authority requires it. The UK sexual health guidance requires extra protection for medicines that are proven to induce liver enzymes, and ashwagandha is not on that list. If you want a safety margin until things are clearer, a barrier method does not interact with anything and does not undermine anything.
The difference is that St John’s wort has been measured in people. In a 2024 study of 11 healthy volunteers, it sped up the clearance of a marker drug 1.96 times at 300 mg a day and 5.62 times at 1,800 mg a day. Ashwagandha has no curve of that kind. It has a result in cultured cells.
No. The UK guidance says that the levonorgestrel IUD and the copper IUD do not lose effectiveness even in the presence of proven enzyme inducers, because they act locally. The same note applies to the progestogen injection. The combined pill, the progestogen-only pill and the implant are the only ones for which the question would make sense.
There are two discussions here, not one. The documented interaction is the one with thyroid treatment, not with the pill, and it is why we have a separate article on ashwagandha and the thyroid. With a regimen that includes levothyroxine, do not add ashwagandha without asking the doctor who adjusts your dose.
Yellowing of the skin or the whites of the eyes, dark urine, pale stools, itching without a rash, nausea that does not go away, pain under the right ribs and unusual tiredness. These are signs of liver distress. Stop the supplement and see a doctor, do not wait for it to pass on its own.
Note: the information in this article is for educational purposes. It does not replace personalised medical advice and does not replace a conversation with the doctor who prescribed your contraception. Ashwagandha has no authorised health claims in the European Union, and this article does not attribute any health effect to it. Food supplements are not medicines and are not intended to diagnose, treat or prevent disease. Do not exceed the recommended daily dose. Keep out of the reach of children.
Comments (0)
There are no comments for this article. Be the first one to leave a message!